|
The following stocks are the leading risers and fallers on AIM on Wednesday. ---------- AIM - WINNERS ---------- Premier African Minerals Ltd, up 42% at 0.035 pence, 12-month range 0.0104p-0.0675p. The developer of RHA tungsten and Zulu lithium projects in Zimbabwe announces the completion of the original equipment manufacturer plant test run’s second phase. Says outcomes were positive, ‘to the extent that the plant is now able to run continuously as intended and is now commissioned such that all plant components operate and are integrated and automated to support the ongoing optimisation necessary to continuously meet saleable concentrate grade’. Says both the Zulu project and the OEM are ‘satisfied with the significant progress’, and that the plant has achieved saleable concentrate of spodumene with grades up to 6.2% lithium oxide. Expects this to be ‘achieved consistently’ due to the ongoing optimisation. ‘We are pleased with the progress made so far and remain focused on advancing Zulu from its current early stage to the diversified industrial minerals producer we believe it can become,’ says Chief Executive Officer George Roach. ‘The recent rise in spodumene pricing is encouraging, with the potential to transition Zulu from its current position to sustained profitability.’ ---------- Inspiration Healthcare Group PLC, up 14% at 23.90 pence, 12-month range 12.5p-27.5p. The Croydon, London-based developer and manufacturer of neonatal intensive care medical devices issues a trading update for the half year ended July 31. Says revenue for the period has increased 41% to £24.0 million, from £17.0 million the year before. This is ‘ahead of market expectations, and represents record half year revenues for the group reflecting the benefits of the back-to-basics approach implemented last year’. Also, its gross margins have improved ‘due to favourable product mix including strong sales of capital items’, and net debt is down to £6.7 million at July 31, from £8.3 million at January 31 ‘due to the strong trading performance...combined with an improving working capital position’. Says its $6 million contract with contract with a humanitarian aid organisation was fully delivered during the half year, and that the Middle Eastern contract is also progressing. Adds that it expects the period’s strong sales momentum to continue into the second half. ‘I am pleased to report that we have had a robust first half performance and continue to see the benefits of our turnaround strategy....we are seeing clear evidence that our disciplined ’back-to-basics’ approach is driving financial recovery and setting a solid foundation for continued momentum into the second half of the year and beyond,’ comments CEO Raffi Stepanian. ‘Our pipeline is strong and we are continuing an upward trajectory. We remain confident in delivering our full-year expectations,’ he adds. ---------- AIM - LOSERS ---------- Fevertree Drinks PLC, down 8.3% at 865p, 12-month range 29.5p-48.5p. Exane BNP has cut its recommendation for the London-based premium drink mixer company to ’underperform’. Gives a price target of 740 pence. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
